Skip to content

The Connection Between Areas in the Brain of Blind Patients

Connectivity of Occipital and Somatosensory Cortical Areas in Blind Subjects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001926
Enrollment
45
Registered
1999-11-04
Start date
1999-04-30
Completion date
2003-11-30
Last updated
2008-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blindness, Brain Mapping, Healthy

Keywords

Plasticity, Magnetic Stimulation, PET, Blind, Braille, Transcranial Magnetic Stimulation

Brief summary

The purpose of this study is to test the belief that specific areas of the brain are connected differently in blind patients than patients with sight. In addition, the study will examine the different anatomical connections between brain areas of patients who became blind early in life versus patients who became blind later.

Detailed description

The purpose of this protocol is to test the hypothesis that the anatomical connectivity of occipital and somatosensory areas in early blind subjects differs from that in subjects who became blind later in life and from that in sighted volunteers.

Interventions

DRUGO15
DEVICECadwell rTMS

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
Lead SponsorNIH

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Subjects with late blindness. Subjects with early blindness. Sighted volunteers. Age between 18 and 65 years.

Exclusion criteria

Subjects with personal or family history of seizures or other neurological or demyelinating disorders. Pregnant women tested after urine pregnancy test. Subjects with metal in the cranium except mouth. Subjects with intracardiac lines and implanted medication pumps. Subjects with increased intracranial pressure as evaluated by clinical means. Subjects with cardiac pacemakers. Intake or neuroleptics. Subjects with blindness secondary to degenerative CNS diseases.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026